Published guidance, NICE advice and quality standards

Showing 51 to 60 of 766

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal)	TA941	20 December 2023	20 December 2023
Empagliflozin for treating chronic kidney disease	TA942	20 December 2023	20 December 2023
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes	TA943	19 December 2023	19 December 2023
Risdiplam for treating spinal muscular atrophy	TA755	16 December 2021	15 December 2023
Pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer	TA939	13 December 2023	13 December 2023
Dupilumab for treating eosinophilic oesophagitis in people 12 years and over (terminated appraisal)	TA938	7 December 2023	7 December 2023
Secukinumab for treating moderate to severe hidradenitis suppurativa	TA935	6 December 2023	6 December 2023
Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma after 3 or more treatments (terminated appraisal)	TA936	30 November 2023	30 November 2023
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies (terminated appraisal)	TA933	29 November 2023	29 November 2023
Foslevodopa–foscarbidopa for treating advanced Parkinson's with motor symptoms	TA934	29 November 2023	29 November 2023